This episode, hosted by William Mark Erwin, DC, PhD and Zorica Buser,PhD with the NASS Section on Biologics, introduces biologic therapy to treat DDD with an emphasis on the IVD NP. They discuss challenges faced by the otherwise “hostile” IVD NP environment, define and debate different biologic therapies (proteinbased, cellular based, bodyderived substances, ECMbased) as well as review what forms the putative therapy should be delivered. They wrap up the discussion on what the future may hold in this field.



Hosts –
1. Zorica Buser PhD, MBA
Director of Research
Director of Regenerative Medicine (Spine Restoration)
Gerling Institute | Formerly SpineCare NYC

Research Assistant Professor
Department of Orthopedic Surgery
NYU Grossman School of Medicine

2. W Mark Erwin DC, PhD
Assistant Professor
Divisions of Neurological and Orthopaedic Surgery
University of Toronto

Chief Science Officer
Notogen Inc.